Mark Cuban's new generic drug company is launching its own pharmacy benefit management company, The Wall Street Journal reported Oct. 25.
The company, called the Mark Cuban Cost Plus Drug Company, said the aim of the PBM is to be more transparent about drug costs and share more savings with customers, according to the Journal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,